CD24 and neoplasm: Although ALDH expression was not examined in this study, co-expression of CD44 and CD24 was observed in ∼0.1% of CD133+ CSCs, again suggesting the possibility that multiple, distinct tumor-initiating populations exist in pancreatic adenocarcinoma.